サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1676148

末梢神経損傷の世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2025年～2033年）

Global Peripheral Nerve Injuries Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日
ページ情報
英文 159 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
末梢神経損傷の世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2025年～2033年）
出版日: 2025年03月01日
発行: Value Market Research
ページ情報: 英文 159 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

末梢神経損傷の世界市場規模は、2024年の19億4,000万米ドルから2033年には38億6,000万米ドルに成長し、2026年から2033年の予測期間中に7.93％の堅調な年間平均成長率（CAGR）を示すと予測されます。

末梢神経損傷市場は、神経損傷や関連疾患の発生率が高まるにつれて大きな成長を遂げています。末梢神経損傷は、外傷、手術、医学的状態によって生じることがあり、痛み、脱力、機能喪失につながります。糖尿病などの疾患の有病率の上昇や高齢化人口の増加が、外科的介入、神経修復装置、リハビリ治療などの効果的な治療オプションに対する需要を促進しています。ヘルスケアプロバイダーが患者の予後改善と機能回復を目指す中、末梢神経損傷治療市場の繁栄が期待されています。

技術の進歩は、末梢神経損傷市場の将来を形作る上で重要な役割を果たしています。低侵襲手術や神経移植術などの手術手技の革新が、治療効果を高めています。さらに、最先端の生体材料や神経導管の開発により、損傷した神経の再生と修復が向上しています。メーカー各社が研究開発への投資を続けていることから、末梢神経損傷市場では、さまざまなヘルスケア環境において革新的なソリューションの採用が進むとみられます。

さらに、患者中心のケアとリハビリテーションを重視する傾向が強まっていることも、末梢神経損傷市場の成長軌道に影響を与えています。患者が回復ニーズに対応する包括的なソリューションを求める中、外科的介入とリハビリ治療を組み合わせた統合治療計画に対する需要が高まっています。この動向は、回復を促進し生活の質を向上させる全体論的アプローチを開発するために、ヘルスケアプロバイダー、リハビリテーション専門家、テクノロジー企業間の協力を促進しています。市場が進化を続ける中、技術の統合、患者の関与、集学的治療が成功の重要な要因となるでしょう。

当社のレポートは、様々な業界や市場に関する包括的かつ実用的な洞察をクライアントに提供するために綿密に作成されています。各レポートは、市場情勢を完全に理解するために、いくつかの重要な要素を含んでいます：

市場概要：定義、分類、業界の現状など、市場に関する詳細なイントロダクション。

市場促進要因：市場成長に影響を与える主な促進要因・抑制要因・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析：製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに内訳。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場企業の包括的評価。主要企業が採用する競合力学と主要戦略に関する考察を提供します。

市場予測：過去のデータと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測します。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析：地域ごとの市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネスチャンスを理解するのに役立ちます。

新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象分野を特定します。将来の市場開拓と成長見通しに関する洞察を提供します。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 末梢神経損傷産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 末梢神経損傷の世界市場分析：タイプ別

  • 概要：タイプ別
  • 実績および予測データ分析：タイプ別
  • 神経麻痺
  • 神経弛緩症
  • ニューロメシス

第6章 末梢神経損傷の世界市場分析：治療別

  • 概要：治療別
  • 実績および予測データ分析：治療別
  • 外科的治療
  • 非外科的治療

第7章 末梢神経損傷の世界市場分析：エンドユーザー別

  • 概要：エンドユーザー別
  • 実績および予測データ分析：エンドユーザー別
  • 病院
  • 外来手術センター
  • 専門クリニック
  • その他

第8章 末梢神経損傷の世界市場分析：地域別

  • 地域別の展望
  • イントロダクション
  • 北米の売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州の売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋の売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋
  • ラテンアメリカの売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカの売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ

第9章 末梢神経損傷企業の競合情勢

  • 末梢神経損傷市場の競争
  • 提携・協力・合意
  • 合併・買収
  • 新製品発売
  • その他の開発

第10章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Medtronic Plc
  • Stryker Corporation
  • Baxter International Inc.
  • Axogen Inc.
  • Integra LifeSciences Holdings Corporation
  • Boston Scientific Corporation
  • Abbott Laboratories
  • NeuroPace Inc.
  • NeuroMetrix Inc.
  • Polyganics B.V.
  • Toyobo Co. Ltd.
  • Synovis Micro Companies Alliance Inc.
  • Collagen Matrix Inc.
  • Nuvectra Corporation
  • Nevro Corp
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Type (USD MN)
  • Neuropraxia Market Sales By Geography (USD MN)
  • Axonotmesis Market Sales By Geography (USD MN)
  • Neurotmesis Market Sales By Geography (USD MN)
  • Analysis By Treatment (USD MN)
  • Surgical Market Sales By Geography (USD MN)
  • Non-Surgical Market Sales By Geography (USD MN)
  • Analysis By End-User (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales By Geography (USD MN)
  • Specialty Clinics Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Peripheral Nerve Injuries Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Peripheral Nerve Injuries Report
  • Market Research Process
  • Market Research Methodology
  • Global Peripheral Nerve Injuries Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Type
  • Market Attractiveness Analysis By Treatment
  • Market Attractiveness Analysis By End-User
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Type (USD MN)
  • Neuropraxia Market Sales By Geography (USD MN)
  • Axonotmesis Market Sales By Geography (USD MN)
  • Neurotmesis Market Sales By Geography (USD MN)
  • Global Market Analysis By Treatment (USD MN)
  • Surgical Market Sales By Geography (USD MN)
  • Non-Surgical Market Sales By Geography (USD MN)
  • Global Market Analysis By End-User (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales By Geography (USD MN)
  • Specialty Clinics Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11219104

Global Peripheral Nerve Injuries Market size is anticipated to grow from USD 1.94 Billion in 2024 to USD 3.86 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 7.93% during the forecast period of 2026 to 2033.

The Peripheral Nerve Injuries Market is experiencing significant growth as the incidence of nerve injuries and related disorders increases. Peripheral nerve injuries can result from trauma, surgery, or medical conditions, leading to pain, weakness, and loss of function. The rising prevalence of conditions such as diabetes and the growing aging population are driving the demand for effective treatment options, including surgical interventions, nerve repair devices, and rehabilitation therapies. As healthcare providers seek to improve patient outcomes and restore function, the market for peripheral nerve injury treatments is expected to flourish.

Technological advancements are playing a crucial role in shaping the future of the peripheral nerve injuries market. Innovations in surgical techniques, such as minimally invasive procedures and nerve grafting, are enhancing the effectiveness of treatments. Additionally, the development of advanced biomaterials and nerve conduits is improving the regeneration and repair of damaged nerves. As manufacturers continue to invest in research and development, the peripheral nerve injuries market is likely to see increased adoption of innovative solutions across various healthcare settings.

Moreover, the growing emphasis on patient-centered care and rehabilitation is influencing the peripheral nerve injuries market's growth trajectory. As patients seek comprehensive solutions that address their recovery needs, there is a rising demand for integrated treatment plans that combine surgical interventions with rehabilitation therapies. This trend is driving collaboration between healthcare providers, rehabilitation specialists, and technology firms to develop holistic approaches that enhance recovery and improve quality of life. As the market continues to evolve, the integration of technology, patient engagement, and multidisciplinary care will be key drivers of success.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Type

  • Neuropraxia
  • Axonotmesis
  • Neurotmesis

By Treatment

  • Surgical
  • Non-Surgical

By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Others
  • COMPANIES PROFILED
  • Medtronic plc
  • Stryker Corporation
  • Baxter International Inc.
  • Axogen Inc.
  • Integra LifeSciences Holdings Corporation
  • Boston Scientific Corporation
  • Abbott Laboratories
  • NeuroPace Inc.
  • NeuroMetrix Inc.
  • Polyganics B.V.
  • Toyobo Co. Ltd.
  • Synovis Micro Companies Alliance Inc.
  • Collagen Matrix Inc.
  • Nuvectra Corporation
  • Nevro Corp.
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. PERIPHERAL NERVE INJURIES a€" INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Treatment
    • 3.7.3 Market Attractiveness Analysis By End-User
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL PERIPHERAL NERVE INJURIES MARKET ANALYSIS BY TYPE

  • 5.1. Overview By Type
  • 5.2. Historical and Forecast Data Analysis By Type
  • 5.3. Neuropraxia Historic and Forecast Sales By Regions
  • 5.4. Axonotmesis Historic and Forecast Sales By Regions
  • 5.5. Neurotmesis Historic and Forecast Sales By Regions

6. GLOBAL PERIPHERAL NERVE INJURIES MARKET ANALYSIS BY TREATMENT

  • 6.1. Overview By Treatment
  • 6.2. Historical and Forecast Data Analysis By Treatment
  • 6.3. Surgical Historic and Forecast Sales By Regions
  • 6.4. Non-Surgical Historic and Forecast Sales By Regions

7. GLOBAL PERIPHERAL NERVE INJURIES MARKET ANALYSIS BY END-USER

  • 7.1. Overview By End-User
  • 7.2. Historical and Forecast Data Analysis By End-User
  • 7.3. Hospitals Historic and Forecast Sales By Regions
  • 7.4. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
  • 7.5. Specialty Clinics Historic and Forecast Sales By Regions
  • 7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL PERIPHERAL NERVE INJURIES MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE PERIPHERAL NERVE INJURIES COMPANIES

  • 9.1. Peripheral Nerve Injuries Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF PERIPHERAL NERVE INJURIES INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Medtronic Plc
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Stryker Corporation
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Baxter International Inc.
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Axogen Inc.
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Integra LifeSciences Holdings Corporation
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Boston Scientific Corporation
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. Abbott Laboratories
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. NeuroPace Inc.
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. NeuroMetrix Inc.
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Polyganics B.V.
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. Toyobo Co. Ltd.
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments
  • 10.14. Synovis Micro Companies Alliance Inc.
    • 10.14.1 Company Overview
    • 10.14.2 Company Revenue
    • 10.14.3 Products
    • 10.14.4 Recent Developments
  • 10.15. Collagen Matrix Inc.
    • 10.15.1 Company Overview
    • 10.15.2 Company Revenue
    • 10.15.3 Products
    • 10.15.4 Recent Developments
  • 10.16. Nuvectra Corporation
    • 10.16.1 Company Overview
    • 10.16.2 Company Revenue
    • 10.16.3 Products
    • 10.16.4 Recent Developments
  • 10.17. Nevro Corp
    • 10.17.1 Company Overview
    • 10.17.2 Company Revenue
    • 10.17.3 Products
    • 10.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies